These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3947272)

  • 1. Ampicillin may aggravate clinical and experimental myasthenia gravis.
    Argov Z; Brenner T; Abramsky O
    Arch Neurol; 1986 Mar; 43(3):255-6. PubMed ID: 3947272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate-induced impairment of neuromuscular transmission in human and experimental autoimmune myasthenia gravis.
    Wirguin I; Brenner T; Shinar E; Argov Z
    Ann Neurol; 1990 Mar; 27(3):328-30. PubMed ID: 2158269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.
    Bucknall RC; Dixon A St J; Glick EN; Woodland J; Zutshi DW
    Br Med J; 1975 Mar; 1(5958):600-2. PubMed ID: 1125624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of myasthenia gravis after amoxicillin therapy: a case series.
    Vacchiano V; Solli P; Bartolomei I; Lai G; Liguori R; Salvi F
    Neurol Sci; 2020 Aug; 41(8):2255-2257. PubMed ID: 32296986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats.
    Molenaar PC; Biewenga JE; Van Kempen GT; De Priester JA
    Neuropharmacology; 1993 Apr; 32(4):373-6. PubMed ID: 8497338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluoroquinolone associated myasthenia gravis exacerbation: clinical analysis of 9 cases].
    Wang SH; Xie YC; Jiang B; Zhang JY; Qu Y; Zhao Y; Li Y; Qiao SS; Xu CL
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(17):1283-6. PubMed ID: 24029473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of myasthenia gravis on rat phrenic diaphragm contractile performance.
    van Lunteren E; Moyer M; Kaminski HJ
    J Appl Physiol (1985); 2004 Sep; 97(3):895-901. PubMed ID: 15107414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exacerbation of myasthenia gravis by pefloxacin].
    Vial T; Chauplannaz G; Brunel P; Leriche B; Evreux JC
    Rev Neurol (Paris); 1995 Apr; 151(4):286-7. PubMed ID: 7481384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients.
    Mann R; Blobner M; Jelen-Esselborn S; Busley R; Werner C
    Anesthesiology; 2000 Aug; 93(2):346-50. PubMed ID: 10910480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of myasthenia gravis during imiquimod treatment.
    Wolfe CM; Tafuri N; Hatfield K
    J Drugs Dermatol; 2007 Jul; 6(7):745-6. PubMed ID: 17763602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenic crisis after a renal transplant successfully treated with intravenous immunoglobulin.
    Hwang IH; Lee KN; Kim IY; Lee DW; Lee SB; Kim DS; Song SH; Seong EY; Kwak IS
    Exp Clin Transplant; 2014 Dec; 12(6):555-8. PubMed ID: 24568644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apropos of the pathogenesis of myasthenia gravis].
    Dolzhenko AT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(3):393-8. PubMed ID: 4299667
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil in the therapy of severe myasthenia gravis.
    Schneider C; Gold R; Reiners K; Toyka KV
    Eur Neurol; 2001; 46(2):79-82. PubMed ID: 11528156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia triggered by immune checkpoint inhibitors: New case and literature review.
    Gonzalez NL; Puwanant A; Lu A; Marks SM; Živković SA
    Neuromuscul Disord; 2017 Mar; 27(3):266-268. PubMed ID: 28109638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of experimental autoimmune myasthenia gravis in rabbits with 4-aminopyridine and 3,4-diaminopyridine].
    Li L; Zhang YP
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):358-62. PubMed ID: 7801782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)].
    Cadisch R; Streit E; Hartmann K
    Schweiz Med Wochenschr; 1996 Feb; 126(8):308-10. PubMed ID: 8701248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart disease in myasthenia gravis].
    Mygland A; Gilhus NE; Hofstad H; Aarli JA; Thunold S
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1209-11. PubMed ID: 2333646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.